These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 10139487)

  • 61. On the front lines of care: primary care doctors' office systems, experiences, and views in seven countries.
    Schoen C; Osborn R; Huynh PT; Doty M; Peugh J; Zapert K
    Health Aff (Millwood); 2006; 25(6):w555-71. PubMed ID: 17102164
    [TBL] [Abstract][Full Text] [Related]  

  • 62. National Authority for Health: France.
    Rochaix L; Xerri B
    Issue Brief (Commonw Fund); 2009 Jul; 58():1-9. PubMed ID: 19639712
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Ethical perspectives on health technology assessment.
    ten Have H
    Int J Technol Assess Health Care; 2004; 20(1):71-6. PubMed ID: 15176180
    [TBL] [Abstract][Full Text] [Related]  

  • 64. PERSPECTIVE: SOME CONCLUSIONS FROM MY LIFE IN HEALTH TECHNOLOGY ASSESSMENT.
    Banta HD
    Int J Technol Assess Health Care; 2018 Jan; 34(2):131-133. PubMed ID: 29609663
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Technology assessment in health care: the U.S. perspective.
    Perry S
    Health Policy; 1988; 9(3):317-24. PubMed ID: 10287864
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Technology for the continuous improvement of the quality of health care.
    Racoveanu NT; Johansen KS
    World Health Forum; 1995; 16(2):138-44. PubMed ID: 7794449
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The assessment of diagnostic imaging technologies: a policy perspective.
    Hailey D; McDonald I
    Health Policy; 1996 May; 36(2):185-97. PubMed ID: 10158768
    [TBL] [Abstract][Full Text] [Related]  

  • 68. World health problems.
    Cochrane AL
    Can J Public Health; 1975; 66(4):280-7. PubMed ID: 808261
    [No Abstract]   [Full Text] [Related]  

  • 69. Methods, procedures, and contextual characteristics of health technology assessment and health policy decision making: comparison of health technology assessment agencies in Germany, United Kingdom, France, and Sweden.
    Schwarzer R; Siebert U
    Int J Technol Assess Health Care; 2009 Jul; 25(3):305-14. PubMed ID: 19619349
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A comparative study of drug listing recommendations and the decision-making process in Australia, the Netherlands, Sweden, and the UK.
    Salas-Vega S; Bertling A; Mossialos E
    Health Policy; 2016 Oct; 120(10):1104-1114. PubMed ID: 27665497
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The management of health care technology in nine countries. Summary and analysis.
    Banta HD; Russell LB
    Springer Ser Health Care Soc; 1982; 7():193-237. PubMed ID: 10259694
    [No Abstract]   [Full Text] [Related]  

  • 72. Lessons from abroad.
    Schmidt H; Kreis J
    Hastings Cent Rep; 2009; 39(6):20-2. PubMed ID: 20050367
    [No Abstract]   [Full Text] [Related]  

  • 73. End-user involvement in health technology assessment (HTA) development: a way to increase impact.
    McGregor M; Brophy JM
    Int J Technol Assess Health Care; 2005; 21(2):263-7. PubMed ID: 15921068
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Health technology assessment.
    Kearney B
    J Qual Clin Pract; 1996 Sep; 16(3):131-43. PubMed ID: 8887856
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Interests in health care technology assessment (HCTA) and HCTA training needs in eight European countries: COMETT-ASSESS.
    Szczepura A; Kankaanpää J
    Soc Sci Med; 1994 Jun; 38(12):1679-88. PubMed ID: 8047927
    [TBL] [Abstract][Full Text] [Related]  

  • 76. NICE and new: appraising innovation.
    Ferner RE; Hughes DA; Aronson JK
    BMJ; 2010 Jan; 340():b5493. PubMed ID: 20051468
    [No Abstract]   [Full Text] [Related]  

  • 77. Social science research on medical technology: utility and limitations.
    Banta HD
    Soc Sci Med; 1983; 17(18):1363-9. PubMed ID: 6359452
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Primary care and health. A cross-national comparison.
    Starfield B
    JAMA; 1991 Oct 23-30; 266(16):2268-71. PubMed ID: 1920727
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Measles control in developing and developed countries: the case for a two-dose policy.
    Tulchinsky TH; Ginsberg GM; Abed Y; Angeles MT; Akukwe C; Bonn J
    Bull World Health Organ; 1993; 71(1):93-103. PubMed ID: 8440043
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Interaction initiatives between regulatory, health technology assessment and coverage bodies, and industry.
    Frønsdal K; Pichler F; Mardhani-Bayne L; Henshall C; Røttingen JA; Mørland B; Klemp M
    Int J Technol Assess Health Care; 2012 Oct; 28(4):374-81. PubMed ID: 23062516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.